Joseph K. Belanoff, M.D. is a co-founder and has served as a member of Corcept’s board of directors and as Chief Executive Officer since 1999. Dr. Belanoff is currently a clinical faculty member and has held various positions in the Department of Psychiatry and Behavioral Sciences at Stanford University since 1992. From 1997 to 2001, he served as the Director of Psychopharmacology at the outpatient division of the Palo Alto Veterans Affairs Hospital. Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University's College of Physicians & Surgeons. Robert L. Roe, M.D. joined Corcept as President in October 2001. Dr. Roe has spent more than 30 years in the pharmaceutical and biotechnology industries. From 1999 to 2001, he served as President and Chief Executive Officer of Allergenics, Inc. From 1996 to 1999, Dr. Roe was Executive Vice President, Chief Operating Officer and a director of Cytel Corporation. From 1995 to 1996, he was Executive Vice President, Chief Operating Officer and a director of Chugai Biopharmaceuticals, Inc. From 1992 to 1995, Dr. Roe served as President of the Development Research Division and Senior Vice President of Syntex Corporation. Dr. Roe received his A.B. from Stanford University and his M.D. from the University of California, San Francisco. Caroline Loewy joined the company as Chief Financial Officer in November 2008.  Ms. Loewy most recently served as Chief Financial Officer of Poniard Pharmaceuticals, a publicly traded biopharmaceutical company, where she was a key driver of that company’s corporate strategy, visibility among investors, and led several successful financings.  From 2004-2006 she acted as an independent consultant to a variety of biopharmaceutical companies advising on corporate strategy, business development, and financing.  Ms. Loewy spent 14 years in equity research and corporate finance.  From 2000-2004 she was an Executive Director in biotechnology equity research at Morgan Stanley, providing fundamental analysis and recommendations to investors, as well as strategic advisory services to corporate clients.  She was also a Managing Director in biotechnology equity research at Prudential Securities and held positions in corporate finance at BankAmerica.  Ms. Loewy holds a BA degree from the University of California, Berkeley, and an MBA/MS degree from Carnegie Mellon University. Anne LeDoux became the company’s Vice President & Controller and Chief Accounting Officer in April 2007.  Ms. LeDoux has over 15 years of financial and accounting management experience with public pharmaceutical and biotechnology companies. Prior to joining Corcept as Controller in 2004, Ms. LeDoux served in various financial positions at Aviron, Roche Biosciences and at Syntex Corporation. She was also Vice President and Chief Financial Officer at the Northern California Health Center and Vice President, Finance for the Children’s Hospital of San Francisco. Ms. LeDoux is a Certified Public Accountant and has over 13 years of experience in public accounting, primarily at Coopers and Lybrand. She received her Bachelor of Arts degree in Business from the University of Massachusetts and a law degree from Western New England College, School of Law.